Pharmacokinetics, Safety, and Tolerability of Once‐Daily Intranasal Fluticasone Furoate and Levocabastine Administered Alone or Simultaneously as fluticasone Furoate/Levocabastine Fixed‐Dose Combination

Publisher： John Wiley & Sons Inc

E-ISSN： 2160-7648|5|3|225-231

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.5, Iss.3, 2016-05, pp. : 225-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Once-daily fluticasone furoate feasible in PAR

By  

Inpharma, Vol. 1, Iss. 1579, 2007-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Open‐Label, Randomized, 6‐Way Crossover, Single‐Dose Study to Determine the Pharmacokinetics of Batefenterol (GSK961081) and Fluticasone Furoate When Administered Alone or in Combination

By  

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 5, 2016-09 ,pp. : 399-407

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and Tolerability of Fluticasone Furoate Nasal Spray Once Daily in Paediatric Patients Aged 6-11 Years with Allergic Rhinitis: Subanalysis of Three Randomized, Double-Blind, Placebo-Controlled, Multicentre Studies

By Meltzer Eli O.  

Clinical Drug Investigation, Vol. 29, Iss. 2, 2009-01 ,pp. : 79-86

Adis International

Access to resources Recommend Favorite

Fluticasone Furoate: Intranasal Use in Allergic Rhinitis

By McCormack Paul L.   Scott Lesley J.  

Drugs, Vol. 67, Iss. 13, 2007-01 ,pp. : 1905-1915

Adis International

Access to resources Recommend Favorite

Safety, tolerability, pharmacokinetics, and pharmacodynamics of fluticasone furoate, a novel inhaled corticosteroid, in children aged 5–11 years with persistent asthma: A randomized trial

By  

Clinical Pharmacology In Drug Development, Vol. 3, Iss. 2, 2014-03 ,pp. : 144-150

John Wiley & Sons Inc

Access to resources Recommend Favorite